Theiler's Murine Encephalomyelitis Virus as a Vaccine Candidate for Immunotherapy

• Kevin D. Pavelko,

  Affiliation Department of Immunology, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Megan A. Girtman,

  Affiliation Department of Immunology, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Yoshihiro Mitsunaga,

  Current address: Tagawa-shinsei Hospital, Tagawa, Fukuoka, Japan

  Affiliation Department of Immunology, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Yanice V. Mendez-Fernandez,

  Current address: Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America

  Affiliation Department of Immunology, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Michael P. Bell,

  Affiliation Department of Immunology, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Michael J. Hansen,

  Affiliation Department of Immunology, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Kathleen S. Allen,

  Affiliation Department of Immunology, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Moses Rodriguez,

  Affiliations Department of Immunology, Mayo Clinic, Rochester, Minnesota, United States of America, Department of Neurology, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Larry R. Pease

  * E-mail: pease.larry@mayo.edu

  Affiliation Department of Immunology, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯